CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | Butler John P. CEO and President | Exercise or conversion | +350,000 | $0.63 | $221K | 3,718,564 |
| 2026-08-06 | Butler John P. CEO and President | Exercise or conversion · Stock Option (Right to buy) | −350,000 | 525,000 | ||
| 2026-03-04 | Butler John P. CEO and President | Purchase | +69,270 | $1.25 | $87K | 3,367,064 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −46,660 | $1.39 | $65K | 3,417,189 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −96,065 | $1.39 | $134K | 3,321,124 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −114,891 | $1.39 | $160K | 3,206,233 |
| 2026-02-02 | Butler John P. CEO and President | Grant or award 10b5-1 | +175,250 | $1.41 | $247K | 3,381,483 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −83,689 | $1.39 | $116K | 3,297,794 |
| 2026-01-30 | Butler John P. CEO and President | Grant or award | +743,000 | 3,463,849 | ||
| 2026-01-30 | Butler John P. CEO and President | Grant or award · Stock Option (Right to buy) | +1,115,000 | 1,115,000 | ||
| 2025-03-03 | Butler John P. CEO and President | Sale 10b5-1 | −46,409 | $1.83 | $85K | 2,557,921 |
| 2025-02-03 | Butler John P. CEO and President | Sale 10b5-1 | −46,268 | $2.10 | $97K | 2,702,312 |
| 2025-02-03 | Butler John P. CEO and President | Sale 10b5-1 | −97,982 | $2.10 | $206K | 2,604,330 |
| 2025-01-31 | Butler John P. CEO and President | Grant or award 10b5-1 | +701,000 | 2,748,580 | ||
| 2025-01-31 | Butler John P. CEO and President | Grant or award · Performance Stock Units 10b5-1 | +350,500 | 350,500 | ||
| 2025-01-31 | Butler John P. CEO and President | Grant or award · Stock Option (Right to buy) 10b5-1 | +1,051,400 | 1,051,400 | ||
| 2024-02-29 | Butler John P. CEO and President | Sale | −46,570 | $1.58 | $74K | 2,044,580 |
| 2024-02-27 | Butler John P. CEO and President | Sale | −37,733 | $1.52 | $57K | 2,091,150 |
| 2024-02-01 | Butler John P. CEO and President | Sale | −46,489 | $1.68 | $78K | 2,128,883 |
| 2024-01-31 | Butler John P. CEO and President | Grant or award | +603,500 | 2,175,372 |
Page 1 of 4 · 74 trades